SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950133-04-001375
Filing Date
2004-04-14
Accepted
2004-04-14 16:33:26
Documents
1
Group Members
BIOTECH INVEST N.V.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G w96195sc13g.htm SC 13G 81573
  Complete submission text file 0000950133-04-001375.txt   83629
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43329 | Film No.: 04733432
SIC: 2834 Pharmaceutical Preparations

Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300
Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 0000